🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
Apatinib mesylate is a multitarget receptor tyrosine kinase inhibitor. This...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-08-20
Trial ID
NCT04012827
Treatments Being Tested
Antibody-dependent cell-mediated cytotoxicity (ADCC) is one of the importan...
Status
Unknown
Location
Shusen Wang
Start Date
2021-06-25
Trial ID
NCT04941885
Treatments Being Tested
This protocol is an international, multicenter, comparative, open and rando...
Status
Unknown
Location
Hospital Universitário Clementino Fraga Filho
Start Date
2007-01
Trial ID
NCT01532856
This study will treat participants with newly diagnosed, low, intermediate ...
Status
Active Not Recruiting
Location
University of Florida Proton Therapy Institute
Start Date
2013-12-04
Trial ID
NCT01871766
The urgent need for new effective therapy for T-cell lymphoma patients and ...
Status
Completed
Location
National Cancer Center
Start Date
2010-07
Trial ID
NCT01198665
Treatments Being Tested
This study is being done to test a transplant method that may have fewer si...
Status
Suspended
Location
St. Jude Children's Research Hospital
Start Date
2020-04-30
Trial ID
NCT04362293
Previous studies have shown that TNBC is sensitive to DNA crosslinking-rela...
Status
Completed
Location
Henan Cancer Hospital
Start Date
2018-11-23
Trial ID
NCT04664972
Treatments Being Tested
This is a phase II, single-arm, open-label study to evaluate the efficacy a...
Status
Unknown
Location
Shanghai Pulmonary Hospital
Start Date
2021-01-31
Trial ID
NCT04667793
Treatments Being Tested
This study will use a combination of four oral drugs (thalidomide, cyclopho...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2001-06
Trial ID
NCT00165451
Treatments Being Tested